Global Breast Imaging Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

 Breast Imaging Market Size

• The global breast imaging market size was valued at USD 5.21 billion in 2024 and is expected to reach USD 10.37 billion by 2032, at a CAGR of 8.97% during the forecast period
• This growth is driven by factors such as the rising prevalence of breast cancer, increasing awareness about early detection, and advancements in imaging technologies such as 3D mammography and AI-based diagnostics

Breast Imaging Market Analysis

• Breast imaging technologies are essential diagnostic tools used for the early detection, diagnosis, and monitoring of breast diseases, especially breast cancer. Key modalities include mammography, ultrasound, MRI, and tomosynthesis
• The demand for breast imaging is significantly driven by the rising incidence of breast cancer, increasing awareness about early screening, and the development of advanced imaging technologies such as 3D mammography and AI-based tools
• North America is expected to dominate the breast imaging market with a market share of 38.3%, due to well-established healthcare infrastructure, high awareness levels regarding breast cancer screening, and strong adoption of advanced imaging technologies such as 3D mammography and MRI
• Asia-Pacific is expected to be the fastest growing region in the breast imaging market with a CAGR of 10.4%, during the forecast period due to increasing awareness of breast cancer, improving access to diagnostic services, and rising healthcare investments
• Ionizing breast imaging technologies segment is expected to dominate the market with a market share of 63.7% due to its widespread use in routine breast cancer screening, particularly digital mammography and tomosynthesis

Report Scope and Breast Imaging Market Segmentation      

Breast Imaging Market Trends

“Technological Advancements & AI Integration in Breast Imaging”

• One prominent trend in the breast imaging market is the rapid integration of artificial intelligence (AI) and machine learning algorithms into imaging systems to enhance diagnostic accuracy and workflow efficiency
• These innovations assist radiologists by improving lesion detection, reducing false positives/negatives, and enabling automated image analysis for faster decision-making 
  • For instance, AI-powered 3D mammography systems are now capable of identifying suspicious areas with high precision, supporting early detection and personalized treatment planning, particularly in dense breast tissues 
• These advancements are revolutionizing breast imaging by increasing diagnostic confidence, reducing radiologist workload, and driving the adoption of next-generation imaging technologies across healthcare systems

Breast Imaging Market Dynamics

Driver

“Rising Incidence of Breast Cancer and Emphasis on Early Detection”

• The growing global incidence of breast cancer is a major driver of the breast imaging market, as early detection significantly improves treatment outcomes and survival rates
• Health organizations and governments are increasingly emphasizing routine screening programs and awareness campaigns to promote early diagnosis through advanced imaging techniques
• The need for accurate, non-invasive, and early diagnostic tools is propelling the adoption of digital mammography, ultrasound, MRI, and AI-integrated imaging solutions

For instance,

• According to the World Health Organization (WHO), breast cancer became the most commonly diagnosed cancer globally in 2021, accounting for 12% of all new annual cancer cases worldwide, highlighting the urgent need for efficient screening and diagnosis tools 
• As breast cancer rates continue to rise, so does the demand for reliable and precise imaging technologies, driving the global growth of the breast imaging market

Opportunity

“AI Integration and Personalized Breast Cancer Screening”

• The integration of artificial intelligence (AI) in breast imaging presents a significant opportunity to improve early cancer detection, reduce diagnostic errors, and enable personalized screening strategies based on individual risk profiles
• AI-powered imaging systems can analyze mammograms, ultrasounds, and MRIs with high precision, identifying subtle abnormalities that may be missed by the human eye, thus enhancing radiologists’ diagnostic confidence
• Moreover, AI can help stratify patients by risk level, enabling tailored screening intervals and imaging techniques, which optimizes healthcare resources and improves patient outcomes

For instance,

• In October 2024, a study published in The Lancet Digital Health demonstrated that AI-assisted mammography interpretation significantly reduced recall rates and improved cancer detection accuracy in population-based breast cancer screening programs across Europe 
• With increasing emphasis on precision medicine, the adoption of AI in breast imaging offers a transformative opportunity to advance screening programs, reduce costs, and save lives through earlier and more accurate diagnosis

Restraint/Challenge

“High Cost of Advanced Imaging Technologies Limiting Adoption”

• The high cost of advanced breast imaging technologies, such as 3D mammography, breast MRI, and automated breast ultrasound systems (ABUS), presents a significant barrier to widespread adoption, especially in low- and middle-income countries
• These imaging systems often require substantial investment not only in equipment but also in skilled personnel, infrastructure upgrades, and ongoing maintenance
• As a result, many healthcare providers, particularly in resource-limited settings, continue to rely on conventional 2D mammography, which may limit the accuracy of early breast cancer detection

For instance,

• According to a 2023 report by the Radiological Society of North America (RSNA), the average cost of installing a digital breast tomosynthesis (3D mammography) system in the U.S. ranges between USD 300,000 and USD 500,000, which may be prohibitive for smaller facilities and rural health centers 
• This financial constraint can hinder market penetration, contribute to disparities in access to high-quality breast cancer screening, and slow the global adoption of cutting-edge breast imaging solutions

Breast Imaging Market Scope

The market is segmented on the basis of technologies and end user.

In 2025, the ionizing breast imaging technologies is projected to dominate the market with a largest share in technologies segment

The ionizing breast imaging technologies segment is expected to dominate the breast imaging market with the largest share of 63.7% in 2025 due to its widespread use in routine breast cancer screening, particularly digital mammography and tomosynthesis. These technologies offer high-resolution imaging and proven diagnostic accuracy for early cancer detection. Their established clinical effectiveness, accessibility, and continued integration with AI tools further reinforce their dominance in the market

The hospital is expected to account for the largest share during the forecast period in end user market

In 2025, the hospital segment is expected to dominate the market with the largest market share of 42.7% due to its access to advanced imaging technologies, presence of skilled radiologists, and ability to handle a high volume of patients. Hospitals often serve as primary centers for cancer diagnosis and treatment, offering comprehensive services including screening, diagnostics, and follow-up care. Their strong infrastructure and integration with government and private screening programs further drive this dominance

Breast Imaging Market Regional Analysis

“North America Holds the Largest Share in the Breast Imaging Market”

• North America dominates the breast imaging market with a market share of estimated 38.3%, driven, by well-established healthcare infrastructure, high awareness levels regarding breast cancer screening, and strong adoption of advanced imaging technologies such as 3D mammography and MRI
• U.S. holds a market share of 78.5%, due to its robust reimbursement policies, government-supported screening programs such as the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), and ongoing technological innovations
• Increasing rates of breast cancer, early diagnosis initiatives, and the presence of major industry players further strengthen market growth in the region
• In addition, the high healthcare spending, frequent awareness campaigns, and access to skilled radiologists contribute to North America's continued leadership in the global market

“Asia-Pacific is Projected to Register the Highest CAGR in the Breast Imaging Market”

• Asia-Pacific is expected to witness the highest growth rate in the Breast Imaging market with a CAGR of 10.4%, driven by increasing awareness of breast cancer, improving access to diagnostic services, and rising healthcare investments
• Countries such as China, India, and South Korea are becoming major contributors due to large patient populations, a growing middle class, and increasing government focus on cancer screening initiatives
• Japan remains a leading market in the region, driven by advanced imaging capabilities and widespread adoption of AI-enhanced diagnostic systems in clinical practice
• India is projected to register the highest CAGR in the breast imaging market, driven by expanding healthcare infrastructure, rising breast cancer incidence, and increasing public-private partnerships promoting early detection and access to quality care

Breast Imaging Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Koninklijke Philips N.V. (Netherlands)
• Hitachi, Ltd. (Japan)
• Siemens Healthineers AG (Germany)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• General Electric Company (U.S.)
• Aspect Imaging Ltd. (Israel)
• Bruker (U.S.)
• Aurora Health Care (U.S.)
• FONAR Corp. (U.S.)
• Esaote SPA (Italy)
• Neusoft Corporation (China)
• Toshiba Corporation (Japan)
• Sanrad (India)
• FUJIFILM Corporation (Japan)
• ONEX Corporation (Canada)
• Hologic, Inc. (U.S.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
• Imaging Diagnostic Systems, Inc. (U.S.)
• Agfa-Gevaert Group (Belgium)
• Koning Health (China)

Latest Developments in Global Breast Imaging Market

• In April 2025, Guardant Health presented data demonstrating the strong performance of its Shield Multi-Cancer Detection (MCD) test across 10 tumor types, including breast cancer. The test exhibits high specificity and clinically meaningful sensitivity, with results informing the National Cancer Institute's selection of the Shield MCD test for the highly anticipated Vanguard Study
• In February 2025, Philips showcased new AI-enabled systems, intelligent software, and imaging cloud services at the European Congress of Radiology (ECR) 2025. These innovations aim to streamline radiology workflows and advance clinical insights, enhancing the efficiency and accuracy of breast imaging procedures
• In February 2025, the UK's National Health Service (NHS) launched the world's most extensive trial of AI in breast cancer diagnosis, analyzing approximately 700,000 mammograms over several years. The trial seeks to evaluate AI's accuracy compared to radiologists, with the potential to reduce workload and expedite diagnoses
• In October 2024, Densitas announced a strategic collaboration with the Medical Technology Management Institute (MTMI) to integrate MTMI’s educational content into Densitas’ intelliMammo platform. This partnership aims to provide continuous quality improvement in mammography by offering technologists access to expert educational materials, including positioning videos, thereby enhancing clinical image quality and patient care
• In March 2024, Hologic introduced its Genius AI Detection technology. This deep-learning software assists radiologists in detecting subtle potential cancers in breast tomosynthesis images, improving diagnostic accuracy and workflow efficiency. The technology is designed to categorize and prioritize cases by complexity, aiding in expedited patient care 

SKU-13947